Status:
RECRUITING
Recovery Rate in Secondary Hypothyroidism
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Secondary Hypothyroidism
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this project is to assess the rate of recovery of secondary hypothyroidism in patients with pituitary disorders.
Detailed Description
The study will be conducted in three stages. Stage 1 ( Patient identification and enrollment) We will generate a list of all SHT patients from the HNP database and all patients will be contacted by ...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of secondary hypothyroidism who are currently taking T4 replacement therapy
Exclusion
- uncontrolled cardiovascular disease
- uncontrolled congestive heart failure
- uncontrolled mental health disorder
- not adequately replaced and have low T4 level.
Key Trial Info
Start Date :
April 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05276856
Start Date
April 4 2022
End Date
December 31 2025
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nova Scotia Health
Halifax, Canada